Objectives: Long non-coding RNAs have identified to involve into the tumour cell proliferation, apoptosis and metastasis. We previously found that up-regulated LncRNA-SNHG7 (SNHG7) positively correlated to the Fas apoptosis inhibitory molecule 2 (FAIM2) in lung cancer cells with unclear mechanism.
1
Traditionally, lung cancers consists of non-small cell carcinoma and small cell carcinoma (small cell lung carcinoma, SCLC), with the former accounting for approximately 80% of the cases and the remaining 20% of cases are SCLC. The majority of non-small cell lung cancer (NSCLC) patients present with locally advanced or metastatic disease, leading to limited therapeutic options and the overall 5-year survival rates of those patients was approximately 17%. 2, 3 Therefore, understanding of tumour biology and pathogenesis of NSCLC is conducive to clarifying favourable response to targeted therapy.
Currently, the majority of transcribed RNAs in mammalian cells are non-coding RNAs (ncRNAs) with no protein-coding capacity, which are generally divided into 2 major classes based on the following sizes including microRNAs (miRNAs, <200 nt in length), which mediate post-transcriptional gene silencing, and long non-coding RNAs (lncRNAs, >200 nt in length), which act as signals, guides or scaffolds to chromatin to regulate the expression of target genes. 4, 5 The aberrant expression of miRNA and LncRNA was found to be involved into the progression of cancer. [6] [7] [8] [9] miR-34 and let-7 were found to be tumoursuppressive miRNAs in lung cancer, systemic nano-delivery of miR-34
and let-7 suppressed tumour growth via the inhibition of survival signatures including ITGB3 and MAP4K3, which improved the survival advantage. 10, 11 LncRNA-MALAT-1 was up-regulated during the tumourigenesis of lung cancer and demonstrated to be associated with metastasis in NSCLC patients. 12 Fas apoptotic inhibitory molecule 2 (FAIM2) could inhibit Fas-mediated cell death and was found to be overexpressed in SCLC cell lines. 13, 14 In our previous study, we identified that the expression of lncRNA-SNHG7 (SNHG7) was enhanced in lung cancer and positively correlated to FAIM2 to promote tumour proliferation and survival in vitro. 15 However, the potential regulation mechanism of SNHG7/FAIM2 is unclear in lung cancer.
Interestingly, the cross-regulations between miRNAs and lncRNAs have been found in many diseases, including cancer. 16, 17 The miRNAs can target lncRNAs to reduce lncRNA stability, whereas lncRNAs can also function as competitive endogenous RNA (ceRNA) to antagonize miRNAs or lncRNAs compete with miRNAs to modulate miRNAs availability to silence target mRNAs. 4 During the lung carcinogenesis, an oncogenic gene LncRNA-UCA1 was highly up-regulated and competitively spongeing miR-193a-3p to increase its target gene ERBB4 levels for the development of NSCLC. 18 LncRNA-NEAT1 was found to accelerate NSCLC cell growth and metastasis, and functioned as a ceRNA for hsa-miR-377-3p to de-repress its endogenous targets E2F3.
19
In this study, we uncovered that high SNHG7 levels predicted a poor clinical outcomes in patients with lung cancer. Besides, SNHG7
functioned as ceRNA to competitively inhibit miR-193b availability, which down-regulated the miR-193b levels to enhance its target gene FAIM2-induced tumour survival, anti-apoptosis and metastasis.
Knockdown of SNHG7 efficiently inhibits tumour growth with decreased miR-193b/FAIM2 signature in vivo.
| MATERIALS AND METHODS

| Tumour samples, cell lines and reagents
In this study, NSCLC tissues (n = 25) and corresponding relative nor- 
| Luciferase reporter assay
The A549 and H125 cells were co-transfected containing psiCHECK2- 
| RNA isolation and qRT-PCR
| Cell transfection
The A549 and H125 cells were cultured to about 80% confluence in 
| CCK-8 assay
A549 cells were transfected with negative control, miR-193b mimics and/or pcDNA3.0-FAIM2/SNHG7 for 48 hours, and the cells were harvested and washed with PBS and then cell counting kit-8
(Kumamoto, Japan) mixed with DMEM was used for cell viability assay, and the absorbance was measured at 450 nm by a microplate reader.
| Transwell assay
2 × 10 4 A549 and H125 cells transfected with negative control, miR193b mimics and/or pcDNA3.1-FAIM2/SNHG7 were in the upper chamber of a non-coated transwell insert for the migration assay, and for the invasion assay, the upper chamber of the transwell inserts were coated with Matrigel, and tumour cells were plated in the upper chamber of the Matrigel-coated transwell insert. Cells that did not migrate or invade were removed using a cotton swab and were stained by crystal violet and counted under an inverted microscope.
Five random views were selected to count the cells.
| Flow cytometry assay
For the cell apoptosis, 2 μL of annexin V mixed with 2 μL of propidium iodide (eBioscience, Waltham, Massachusetts) was used to stain cells and analysed using a flow cytometry provided with the Cell-Quest software.
| Western blotting
The tumour tissues were collected and the protein was abstracted.
According to the manufacturer's instructions, proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane (Bio-Rad, Hercules, CA, USA) and were blocked in 5% non-fat milk in TBST buffer (tris buffer saline containing 0.1% Tween-20) for 1 hour at room temperature, and subsequently incubated with anti-GAPDH, E-cadherin and N-cadherin antibodies overnight at 4°C. After washing with TBST buffer, the blots were then incubated with HRP-conjugated secondary antibody for 1 hour at room temperature. The blots were washed with TBST buffer and visualized using the ECL-Plus reagent (Millipore, Billerica, MA, USA). GAPDH was used as the loading control in the Western blotting. 
| Tumour model
| Statistical analyses
used to compare the 2 groups, and multiple group comparisons were analysed with 1-way ANOVA. P < .05 was considered statistically significant. All experiments were performed at least 3 times.
| RESULTS
| High expression of SNHG7 correlates to poor clinical outcome
We previously reported that the expression of SNHG7 was elevated in NSCLC, but the correlations between the clinicopathological characteristics of NSCLC patients and SNHG7 expression were unknown.
NSCLC tissues (n = 25) were collected to determine the SNHG7 level and the Q-PCR results showed that the SNHG7 level positively correlated to the high TNM stage ( Figure 1A ) and lymph node metastases ( Figure 1B) . Thus, high expression of SNHG7 in clinical was an oncogene during the development of NSCLC.
| SNHG7 as ceRNA contains functional miR193b interaction sites
Because we have found that the expression of FAIM2 positively correlated to SNHG7 levels in lung cancer with unclear mechanism, we speculated that SNHG7 could modulate miRNA that target FAIM2 to control the FAIM2 levels in NSCLC. Bioinformatic analysis uncovered that human SNHG7 harboured putative complementary sequences for miR-193b and one predicted miR-193b-binding sites (7 bp) were found ( Figure 2A ).
Then, we conducted the plasmid psiCHECK2-miR-193b which Figure 2C ).
These data indicated the ceRNA role of SNHG7 to antagonize miR193b availability in lung cancer cells.
| FAIM2 is directly targeted by miR-193b
We have demonstrated that SNHG7 could inhibit the miR-193b function, thus we next analysed the relationship between miR-193b and
FAIM2. The expression of miR-193b was decreased in NSCLC tissues
and lung cancer cell lines ( Figure 3A) , which was negatively associ- 
| SNHG7 promotes tumour growth and metastasis via miR-193b/FAIM2 signals
In our previous study, we found that FAIM2 promoted the proliferation and inhibited the apoptosis of A594 cells. Thus, we next investigated the impacts of miR-193b on FAIM2 function in A549 and H125 cells. The 
| Knockdown of SNHG7 restricts the development of lung cancer in vivo
To confirm the oncogene role of SNHG7 in vivo, the xenograft model of human A549 and H125 cells was established and the nude mice were administrated of conditional tumour cells with SNHG7 overexpression or knockdown. Knockdown of SNHG7 significantly restricted the tumour growth with small tumour volume, whereas the mice treated with overexpressed SNHG7 bared the largest tumour ( Figure 5A ). The expression of SNHG7, miR-193b and FAIM2 was determined and found that SNHG7 in vivo inhibits the miR-193b level to up-regulate FAIM2 ( Figure 5B) . Besides, the expression of epithelial marker E-cadherin was dramatically reduced in mice with SNHG7
overexpression, but expression of mesenchymal marker N-cadherin was significantly up-regulated. (Figure 5C ,D).
| DISCUSSION
Lung cancer is being the most common incident cancer in china, and the leading cause of cancer death in 2015. 20 Retrospective data showed and H125 cells were transfected with full-length 3′-UTR (wild type or mutant) of FAIM2, and the luciferase reporter was performed to confirm the direct target sites. **P < .01, ***P < .001, data represent the means ± SD | 7 of 9 SHE Et al.
that the prognosis for advanced-stage lung cancer is very poor, with a 5-year overall survival rate of 17%. Besides, the 5-year overall survival rate for widely disseminated disease only has 4.2%. 3 Therefore, understanding the mechanism of proliferation and metastasis of lung cancer favoured to find new target of therapy. Non-coding RNAs (ncRNAs)
have been proposed to be effective targets of cancer therapy. 21 We here found that we uncovered that high SNHG7 levels predicted a poor were oncogene but MEG3 was a tumour suppressor in lung cancer.
F I G U R E 4 SNHG7 regulates FAIM2-induced tumour growth and metastasis via miR-193b. (A) The A549 and H125 cells were transfected with negative control, miR-193b mimics and/or pcDNA3.0-FAIM2, the proliferation was estimated by CCK-8, (B) the migrations and invasions of 2 tumour cells were determined by transwell assay and (C) the apoptosis was estimated by flow cytometry. (D) Overexpression of SNHG7 in A549 and H125 cells, the miR-193b and FAIM2 levels was estimated. (E-G) The A549 and H125 cells were transfected with negative control, miR-193b mimics and/or pcDNA3.1-SNHG7, the proliferation, migrations and invasions, and apoptosis were analysed. *P < .05, **P < .01, ***P < .001, data represent the means ± SD were estimated by Q-PCR. The expression of EMT markers (E-cadherin and Ncadherin) was assessed by Q-PCR (C) and WB (D). *P < .05, **P < .01, data represent the means ± SD Amounting evidences over the past decade have also begun to uncover the interaction among mammalian lncRNAs and miRNAs.
The interaction among mammalian lncRNAs and miRNAs was the important mechanism for lncRNA to exert its anti-or pro-tumour function. 4 Zhuang et al 24 cells. 28 In this study, SNHG7 modulated miR-193b availability by acting as a molecular sponge, which down-regulated the miR-193b levels to enhance its target gene FAIM2-induced tumour survival,
anti-apoptosis and metastasis.
In conclusion, we found that miR-193b was required for SNHG7
to induce FAIM2-supported proliferation, anti-apoptosis and metastasis of lung cancer. We highlighted the ceRNA role of SNHG7 during FAIM2-related carcinogenesis. Knockdown of SNHG7 in vivo could be a promising target therapy for lung cancer.
